When the PPC asks how personal information was handled by an automated system under the APPI, when the FSA asks who was accountable for an AI-driven financial decision and how it was reached, when the PMDA asks for the change-control and post-market evidence behind AI-enabled medical-device software — KYE Protocol™ answers from a record sealed at the moment of action. Replayable from the publishing tenant's JWKS alone. No vendor dependency in the audit path.
Japan's federal data-protection law, supervised by the Personal Information Protection Commission (PPC). Purpose-of-use limitation maps to Purpose Permission™; security control measures to Authority Resolution™ + the Data Classification Engine; cross-border transfer and disclosure/access rights to the Cross-Border Evidence agent, Decision Map™ and Replay-Proof™. Each obligation is a per-requirement bijection row.
The Financial Services Agency's AI governance and model-risk expectations for financial institutions. Accountability maps to Purpose Permission™; model risk to the Risk Engine, Conformance Runner and Drift Detector; human oversight to GovernedUI™; explainability to the Decision Map™ and Evidence Pack™. Each expectation is a per-requirement bijection row.
The PMDA's SaMD review pathway under the PMD Act, including the two-step (DASH) approval scheme. Quality-management-system evidence and clinical-evaluation provenance map to the WORM audit + Evidence Pack™; change control to the Conformance Runner + Drift Detector; human oversight to GovernedUI™. Device classification and marketing approval remain the manufacturer's submission.
Japan-sovereign deployment
Japanese data, Japanese keys, Japanese control.
Data residency — deploy to Japanese-region edge runtime resources; per-tenant configurable; structured datastore + object store pinned to Japan.
Customer KMS — signing keys live in the customer's HSM or sovereign-cloud KMS; KYE™ never has access to the private key material.
Open verifier — the PPC, the FSA, the PMDA and the customer's own auditors can replay an Evidence Pack™ using only the publisher's JWKS. No vendor dependency in the audit path.
Apache 2.0 schemas + vocabulary — the contracts the customer relies on are open. The patent-track runtime construction is paid; the proof formats are not.
Japanese pilot · 6 weeks
KYE Japanese Readiness Pilot™.
Japanese banks, insurers, asset managers, medical-device manufacturers and AI-deploying enterprises: a 6-week shadow-mode engagement producing APPI personal-data handling evidence per assertion, FSA AI-governance and model-risk coverage, PMDA SaMD change-control and post-market evidence where applicable, signed Evidence Packs™ per decision, and a regulator-ready executive summary with a residual-risk register.
Independent — no government affiliation. KYE Protocol™ is an independent protocol and is not affiliated with, endorsed by, or part of any government, regulator, or official “Sovereign AI” programme. References to regulators and frameworks describe the requirements KYE™ helps you evidence — not any official relationship.